期刊论文

Research strategy of drugs against 2019-novel coronavirus based on supramolecular “qi chromatography” theory of TCM

中文

中草药

0253-2670

2020

51

3

557-562

10.7501/j.issn.0253-2670.2020.03.001

国家自然科学基金项目(81573691) 国家自然科学基金项目(81874507) 湖南省教育厅创新平台开放基金项目(18K071) 长沙市科技计划项目(kq1907137).

本校为第一机构

当前2019新型冠状病毒(2019-novel coronavirus,2019-nCoV)肆虐中国,控制疫情蔓延成为头等大事。由于没有特异性的药物进行治疗,给疫情控制造成了极大的困难,因此研究出特效药物迫在眉捷。抗2019-nCoV药物研究总体上遵循3种模式,即疫苗、化学药和中药。由于疫苗、化学药物研究耗时太长,难解燃眉之急,并且冠状病毒的RNA和RNA之间重组率非常高,病毒出现变异正是由于这种高重组率,花巨大精力研究出来的疫苗和药物可能会错过疫情,且对下一代新型冠状病毒感染的治疗效果不确定,使防疫工作变得更加艰巨。用中医药理论遣药组方治疗疫病确有疗效,但将其开发成成分清晰、作用机制明确的特效药物,是亟需解...

At present, the 2019-novel coronavirus (2019-nCoV) is rampant all over the country, and controlling the spread of its epidemic has become a top priority. It is very difficult to control the epidemic spreading because there is no specific drug to fight against it. Therefore, it is urgent task for us to develop a specific drug as soon as possible, and attracting worldwide attention. The studies on anti-2019-nCoV drugs were generally carried out in three modes, as vaccine, chemical drugs and traditional Chinese medicine (TCM). Because the developi...